vs
Aurinia Pharmaceuticals Inc.（AUPH）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是Aurinia Pharmaceuticals Inc.的1.2倍（$94.3M vs $77.1M），Aurinia Pharmaceuticals Inc.净利率更高（273.4% vs 24.2%，领先249.1%），Aurinia Pharmaceuticals Inc.同比增速更快（28.8% vs 5.3%），过去两年Aurinia Pharmaceuticals Inc.的营收复合增速更高（23.8% vs -11.5%）
Aurinia Pharmaceuticals是一家生物制药企业，专注于自身免疫疾病及肾脏疾病靶向疗法的研发与商业化，核心获批产品为用于治疗成人活动性狼疮性肾炎的Lupkynis，主要市场覆盖北美及欧洲地区。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
AUPH vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.2倍
$77.1M
营收增速更快
AUPH
高出23.5%
5.3%
净利率更高
AUPH
高出249.1%
24.2%
两年增速更快
AUPH
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.1M | $94.3M |
| 净利润 | $210.8M | $22.8M |
| 毛利率 | 88.6% | — |
| 营业利润率 | 43.1% | 29.3% |
| 净利率 | 273.4% | 24.2% |
| 营收同比 | 28.8% | 5.3% |
| 净利润同比 | 14651.2% | 20.0% |
| 每股收益（稀释后） | $1.52 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AUPHRBCAA
| Q4 25 | $77.1M | $94.3M | ||
| Q3 25 | $73.5M | $93.5M | ||
| Q2 25 | $70.0M | $93.8M | ||
| Q1 25 | $62.5M | $135.8M | ||
| Q4 24 | $59.9M | $89.5M | ||
| Q3 24 | $67.8M | $88.1M | ||
| Q2 24 | $57.2M | $86.9M | ||
| Q1 24 | $50.3M | $120.3M |
净利润AUPHRBCAA
| Q4 25 | $210.8M | $22.8M | ||
| Q3 25 | $31.6M | $29.7M | ||
| Q2 25 | $21.5M | $31.5M | ||
| Q1 25 | $23.3M | $47.3M | ||
| Q4 24 | $1.4M | $19.0M | ||
| Q3 24 | $14.3M | $26.5M | ||
| Q2 24 | $722.0K | $25.2M | ||
| Q1 24 | $-10.7M | $30.6M |
毛利率AUPHRBCAA
| Q4 25 | 88.6% | — | ||
| Q3 25 | 88.9% | — | ||
| Q2 25 | 89.8% | — | ||
| Q1 25 | 86.3% | — | ||
| Q4 24 | 90.7% | — | ||
| Q3 24 | 91.1% | — | ||
| Q2 24 | 84.4% | — | ||
| Q1 24 | 84.6% | — |
营业利润率AUPHRBCAA
| Q4 25 | 43.1% | 29.3% | ||
| Q3 25 | 40.5% | 40.4% | ||
| Q2 25 | 28.7% | 43.0% | ||
| Q1 25 | 35.0% | 44.1% | ||
| Q4 24 | -2.8% | 25.8% | ||
| Q3 24 | 17.3% | 38.4% | ||
| Q2 24 | -2.6% | 37.0% | ||
| Q1 24 | -26.3% | 32.2% |
净利率AUPHRBCAA
| Q4 25 | 273.4% | 24.2% | ||
| Q3 25 | 42.9% | 31.8% | ||
| Q2 25 | 30.7% | 33.5% | ||
| Q1 25 | 37.4% | 34.8% | ||
| Q4 24 | 2.4% | 21.2% | ||
| Q3 24 | 21.2% | 30.1% | ||
| Q2 24 | 1.3% | 29.0% | ||
| Q1 24 | -21.4% | 25.4% |
每股收益（稀释后）AUPHRBCAA
| Q4 25 | $1.52 | — | ||
| Q3 25 | $0.23 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.16 | — | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $0.10 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.2M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $581.3M | $1.1B |
| 总资产 | $751.6M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AUPHRBCAA
| Q4 25 | $80.2M | $220.0M | ||
| Q3 25 | $72.9M | $484.2M | ||
| Q2 25 | $52.9M | $484.8M | ||
| Q1 25 | $66.1M | $793.0M | ||
| Q4 24 | $83.4M | $432.2M | ||
| Q3 24 | $36.6M | $530.9M | ||
| Q2 24 | $33.3M | $400.1M | ||
| Q1 24 | $63.9M | $546.4M |
股东权益AUPHRBCAA
| Q4 25 | $581.3M | $1.1B | ||
| Q3 25 | $365.8M | $1.1B | ||
| Q2 25 | $335.3M | $1.1B | ||
| Q1 25 | $350.2M | $1.0B | ||
| Q4 24 | $377.5M | $992.0M | ||
| Q3 24 | $388.0M | $979.7M | ||
| Q2 24 | $364.6M | $955.4M | ||
| Q1 24 | $359.5M | $935.6M |
总资产AUPHRBCAA
| Q4 25 | $751.6M | $7.0B | ||
| Q3 25 | $527.5M | $7.0B | ||
| Q2 25 | $502.6M | $7.0B | ||
| Q1 25 | $504.9M | $7.1B | ||
| Q4 24 | $550.6M | $6.8B | ||
| Q3 24 | $549.4M | $6.7B | ||
| Q2 24 | $523.5M | $6.6B | ||
| Q1 24 | $516.6M | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.7M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | — | $161.1M |
| 自由现金流率自由现金流/营收 | — | 170.9% |
| 资本支出强度资本支出/营收 | — | 7.5% |
| 现金转化率经营现金流/净利润 | 0.22× | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流AUPHRBCAA
| Q4 25 | $45.7M | $168.2M | ||
| Q3 25 | $44.4M | $33.3M | ||
| Q2 25 | $44.2M | $8.4M | ||
| Q1 25 | $1.3M | $93.2M | ||
| Q4 24 | $30.1M | $149.0M | ||
| Q3 24 | $17.0M | $51.3M | ||
| Q2 24 | $15.8M | $4.0M | ||
| Q1 24 | $-18.6M | $71.2M |
自由现金流AUPHRBCAA
| Q4 25 | — | $161.1M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | — | $5.2M | ||
| Q1 25 | — | $91.6M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | — | $49.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率AUPHRBCAA
| Q4 25 | — | 170.9% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 67.4% | ||
| Q4 24 | — | 160.0% | ||
| Q3 24 | — | 56.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度AUPHRBCAA
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.7% |
现金转化率AUPHRBCAA
| Q4 25 | 0.22× | 7.37× | ||
| Q3 25 | 1.41× | 1.12× | ||
| Q2 25 | 2.06× | 0.27× | ||
| Q1 25 | 0.06× | 1.97× | ||
| Q4 24 | 21.07× | 7.84× | ||
| Q3 24 | 1.19× | 1.93× | ||
| Q2 24 | 21.94× | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AUPH
| Products | $74.2M | 96% |
| License Collaboration And Royalty Revenue | $2.9M | 4% |
RBCAA
暂无分部数据
